First 100 Patients Treated in Europe with the MitraClip(R) System for Percutaneous Mitral Repair

Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced that the first 100 patients have been treated with the MitraClip(R) system in Europe. Clinical results to date underscore the acute clinical benefit for patients, demonstrate the potential for reduced hospital stays and improved quality-of-life for patients. Of the procedures performed to date, 93% resulted in an implant and the vast majority resulted in a satisfactory reduction of mitral regurgitation, as described by the physician at the time of the procedure. The MitraClip(R) system is the only medical device commercially available in the European Union which provides a...

Want to see the full article?

• Purchase this article for only $3.00